Amy B. Guzman

Amy B. Guzman MBA has diverse work experience in various leadership and strategic roles within the biotechnology and pharmaceutical industries. Amy B. is currently working at Cerevel Therapeutics, where they hold the position of Senior VP, Portfolio and Program Management. Prior to this, they worked at Intergalactic Therapeutics as the VP, Head of Finance and Portfolio Strategy, where they played a vital role in creating a multi-year plan and implementing strategic and financial planning processes. Before that, Amy held the position of Strategy Consultant and Chief of Staff to the CEO at UNITY Biotechnology, where they advised the Executive Leadership Team on governance framework and portfolio prioritization. Additionally, they have extensive experience at Biogen, where they served in various roles including Executive Director, R&D Strategy and Portfolio Leadership, Senior Director, R&D Strategy, Portfolio & Communications, Director, R&D Business Planning, Director, Discovery Planning and Operations, and Associate Director, Clinical Business Operations. Amy also has prior experience at Amylin Pharmaceuticals, RSM McGladrey, and HRG, Inc.

Amy B. Guzman MBA has a strong educational background with a focus on business and marketing. Amy B. obtained their MBA degree from Bentley University - McCallum Graduate School of Business, where they specialized in Marketing and Finance. Prior to their MBA, Amy earned a Bachelor of Science degree in Business Communication from Bentley University. Additionally, they participated in Babson College's Entrepreneurial Leadership Program as part of their executive education.